Tag: ALLK

Closing Out the Short Trading Week

Options Review: 

The end of holiday week one of two is upon us, and it was a pretty good one in terms of the gain opportunities we observed. We expect a subdued end to this short week, but we wanted to swing back around for a couple of longer-term calls we submitted last week in our reports for December 13th (TSM) and December 15th (TKR).

We were tracking the TSM 01/07 $122-124 Calls and the TKR 01/21 $65-70 Calls, and both sets of ideas have gained some good ground this week. Here are the overall increases we’ve witnessed in those ideas so far:

TSM 01/07 $122-124 Calls
$122: .98-2.45 (+150%)
$123:.70-1.68 (+140%)
$124: .70-1.68 (+140%)
_____

TKR 01/21 $65-70 Calls
$65: 1.97-4.10 (+108%)
$67.50: .55-1.24 (+125%)
$70: .08-.25 (+212%)

Fresh Options Idea:
SPY 12/23 $467-469 Calls
CROX 01/21 $150-155 Calls

BiondVax Pharmaceuticals, Inc. BVXV:

We would like to close things out by providing a quick update on BVXV which appeared in yesterday’s extended watchlist. While it did produce a multibag run, it did have two separate moves on the day that are worth mentioning.

First it ran from 2.72-3.49 (+28%), followed by a slight pullback and a move from .2.31-3.00 (+30%) for a cumulative total of 58% on the day. .

Extended Watchlist:
ALLK, KTTA, ENSC, KXIN, QNRX, GNCA, SBES, GTII, CGAC, AXTG

Blue Horseshoe Stocks: Perfectly-Timed Bottom Plays & More

Allakos, Inc. ALLK –  Recap

We began tracking ALLK on Monday morning, and formulated some options ideas ($45-60) which worked for us in Monday’s session, bringing in some nice gain opportunities. Then yesterday rolled around and we shared the huge news reported by the company in our premarket report along with the gains that our options ideas made.

The news on ALLK proved to be very influential on the activity of the stock, pushing it even further than Monday’s big surge had taken it. From the low that morning of 60.34, ALLK has run all the way up to a new high yesterday at 85.40, which marked a two-day upswing of 42%

While the lower end of our tracked options range was too deep in the money to see any real progress, the $60 Calls remained in play, and hit a high of 23.82. From our observed low of 6.75 on Monday, those contracts rose by a whopping 253%
_____

We also signaled interest in the Innovative Industrial Properties, Inc. IIPR 08/16 $100-105 Calls 
yesterday, and those got off to a modest, yet promising start. The $100’s traded in a range from 6.50-7.90 for a rise of 22%, while the $105’s ran 23% from 4.50-5.90. We’ll continue to monitor these ideas into their expiration next week.
_____

Fresh Ideas: 
CVS Weekly $55.50-57 Calls
SPY Weekly $286-285 Puts


Durect Corp DRRX

We also want to highlight the incredible performance that DRRX has had this summer to finish things up this morning. We tagged the stock for observation on May 28th, at which time we observed a low of .50, and it turned out to be a great nbottom call, as it hasn’t looked back since.

Slow and steady growth over the past two months has brought DRRX to a new high of 1.44 this week. That represents an overall increase of 188% in the time we’ve been observing this play.

Extended Watchist: 
MRNA, EVH, CPE, ENDP, AVGR, TVIX, APVO, ONVO

Blue Horseshoe Stocks: Great Start to the Week

T2 Biosystems, Inc. TTOO

This past Thursday morning, we cautioned our readers that TTOO was heavily oversold, and sniffing out a bottom with a massive gap to the upside. As it turned out, our timing on that alert could not have any better. The stock saw its low of .52 that day and hasn’t looked back since. Yesterday, TTOO reached .76 which works out to a three-day upswing of 46%, a modest yet respectable move.

More importantly, the stock is once again taking off on the heels of a fresh PR this morning (below), reaching a new high of 1.13 in premarket trading. That further extends our observed range on this play to 117% as TTOO begins to fill the gap on the chart that we mentioned which runs up to the 1.36 mark.

LEXINGTON, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) announced today that the United States Centers for Medicare & Medicaid Services (CMS) granted approval for a New Technology Add-on Payment (NTAP) for the T2Bacteria® Panel for FY 2020.

The T2Bacteria Panel, the first and only FDA-cleared test to identify sepsis-causing bacterial pathogens directly from whole blood in 3 to 5 hours without the need to wait for blood culture, is now also the first and only in-vitro diagnostic test to ever receive approval for NTAP. (>>View Full PR)

Options Reviews

SPDR S&P500 (ETF) SPY –  As a fresh options idea to start the week yesterday morning, and in light of the bearish market sentiments that we were sensing in the premarket, we went with SPY Weekly $290-288 Puts as our targets. Early indications ultimately proved to be correct, as the markets tanked on the day, sending those contracts on a huge ride.

The following multi-bag gains were there for taking: 

$290 Puts – Range: 2.27-8.19 – Max Gain: 261%
$289.50 Puts – Range: 1.98-7.30 – Max Gain: 269%
$289 Puts – Range: 1.51-7.10 – Max Gain: 370%
$288.50 Puts – Range: 1.29-5.54  – Max Gain: 329%
$288 Puts – Range: 1.18-6.10 – Max Gain: 417%

____

Allakos, Inc. ALLK – We also signaled interest in the ALLK 08/16 $45-60 Calls yesterday in opposition to the market activity we were observing, and those targets bucked the trend quite nicely, with three out of the four producing notable opportunities on the day:

$45 Calls – Range: 16.41-25.53 – Max Gain: 56%
$55 Calls – Range: 9.00-15 60 – Max Gain: 73%
$60 Calls – Range: 6.75-14.20 – Max Gain: 110%
____

Fresh Idea:
Emerson Electric Co. EMR 08/30 $63-64 Calls
Innovative Industrial Properties, Inc. IIPR 08/16 $100-105 Calls

Extended Watchist: 
ACB, ATRS, TOPS, KALA, PAYS, TELL, MYSZ, PLUG, CARS(Bottom-watch)